Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis. - Wikidata - wikimedia - TriplyDB

Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

http://www.wikidata.org/entity/Q33614498

about

Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study.Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomes.Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladder.The landscape of genetics and biomarkers in bladder cancer.Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?

P2860

Q47094005-7177FBBD-FF57-4E44-8ED4-317D897FAAE0 Q48028604-A9D4A3AE-59F1-4AB7-96E7-7938E82E27F8 Q49031712-6CA00ADA-0673-47FC-9ADD-EDAED9772846 Q49479865-DCFAF80A-BDA9-4D83-9577-81A923F6718C Q50203162-AA188FB5-2C04-4BD9-A23A-34B6FDB46138

P2860

Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

http://www.wikidata.org/entity/Q33614498

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Survival after Metastasectomy ...... atic Review and Meta-Analysis.

@ast

Survival after Metastasectomy ...... atic Review and Meta-Analysis.

@en

type

label

Survival after Metastasectomy ...... atic Review and Meta-Analysis.

@ast

Survival after Metastasectomy ...... atic Review and Meta-Analysis.

@en

prefLabel

Survival after Metastasectomy ...... atic Review and Meta-Analysis.

@ast

Survival after Metastasectomy ...... atic Review and Meta-Analysis.

@en

P1433

Q33614498-68EE934C-EF12-4BC8-A431-8193F5D4D6AC

P1476

Q33614498-94337664-AFC7-4AB9-A991-8512B6368E1D

P2093

Q33614498-03B4FBFC-B84D-414D-AB67-952FA81A261F

Q33614498-23BEA0F3-7EE6-4E93-B54F-C055A1746433

Q33614498-2B34F0A5-2236-49B0-8F8A-A5FE420F73FF

Q33614498-6B204639-77F8-470E-99BF-4EB20682B49E

Q33614498-AC549B95-735A-4473-9EDB-02C8397C566C

Q33614498-FB41AEEF-085F-4F14-95D9-674CB31361AA

P2860

Q33614498-01913B64-7A0E-430C-82AD-42FFE1235348

Q33614498-0BBB85A2-9AB9-4925-BD48-AB5F519F0210

Q33614498-307D8645-5110-4112-9B56-897E4C25B4FA

Q33614498-3593B374-2F6A-4906-8282-610101AB76E7

Q33614498-45F3B377-AB73-48FC-A7F1-9175BAF20490

Q33614498-517693C5-9D4B-4647-A32B-85E234D03DEA

Q33614498-528E2F9D-93FA-4305-AD87-1C28962458CA

Q33614498-57C88B37-7496-4332-8BA5-B0B88E898D63

Q33614498-5D572A8A-5009-4C39-9CED-C14907CF335D

Q33614498-658CD99E-2539-46BC-9F22-BFBE2FC66AF2

P304

Q33614498-7C26AB12-27B6-4A49-A37A-D193ED8E8571

P31

Q33614498-422841D0-C02F-4C47-A36F-97FE40FDDA7C

P356

Q33614498-EFC8A701-B0DB-4A4E-83A1-D4DF6AAA5EEB

P433

Q33614498-1498B11E-E19E-48AE-AB6D-A074128B873A

P478

Q33614498-3DD9E5F8-6849-495A-8EEE-BC646F1C6CA7

P50

Q33614498-B27EF49C-479D-4F63-A665-B27F1DDA1A29

P577

Q33614498-94933E86-8379-4D06-A607-3E2A92A91D7B

P698

Q33614498-6F65D23A-1F3A-488B-A104-026FBEDC77D8

P932

Q33614498-D158E1D0-8D5B-42CB-84C0-339E84762057

P356

P1433

Bladder Cancer (Amsterdam, Netherlands)

P1476

Survival after Metastasectomy ...... atic Review and Meta-Analysis.

@en

P2093

Aaron Stern

http://www.w3.org/2001/XMLSchema#string

Ana Collazo Lorduy

http://www.w3.org/2001/XMLSchema#string

Georgios Gakis

http://www.w3.org/2001/XMLSchema#string

Matthew D Galsky

http://www.w3.org/2001/XMLSchema#string

Omar Fahmy

http://www.w3.org/2001/XMLSchema#string

Vaibhav Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Surgical resection of urological tumor metastases following medical treatment

Practical methods for incorporating summary time-to-event data into meta-analysis

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial.

Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.

Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancer.

A comparison of radiotherapy with radiotherapy plus surgery for brain metastases from urinary bladder cancer: analysis of 62 patients.

Conditional Survival in de novo Metastatic Urothelial Carcinoma

Result of surgical resection for pulmonary metastasis from urothelial carcinoma.

P304

121-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/BLC-170108

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28516157

http://www.w3.org/2001/XMLSchema#string

P932

5409038

http://www.w3.org/2001/XMLSchema#string